vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $14.7M, roughly 1.9× IRIDEX CORP). On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CMCT vs IRIX — Head-to-Head

Bigger by revenue
CMCT
CMCT
1.9× larger
CMCT
$28.5M
$14.7M
IRIX
Growing faster (revenue YoY)
CMCT
CMCT
+73.4% gap
CMCT
3.6%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
IRIX
IRIX
Revenue
$28.5M
$14.7M
Net Profit
$-11.4M
Gross Margin
37.2%
Operating Margin
-125.6%
Net Margin
-125.8%
Revenue YoY
3.6%
-69.7%
Net Profit YoY
-11.4%
EPS (diluted)
$-3.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
IRIX
IRIX
Q4 25
$28.5M
$14.7M
Q3 25
$26.2M
$12.5M
Q2 25
$29.7M
$13.6M
Q1 25
$32.3M
$11.9M
Q4 24
$27.5M
$12.7M
Q3 24
$28.6M
$11.6M
Q2 24
$34.4M
$12.6M
Q1 24
$34.0M
$11.8M
Net Profit
CMCT
CMCT
IRIX
IRIX
Q4 25
$-11.4M
Q3 25
$-12.5M
$-1.6M
Q2 25
$-9.0M
$-994.0K
Q1 25
$-6.1M
$-1.7M
Q4 24
$-10.3M
$-834.0K
Q3 24
$-10.4M
$-1.9M
Q2 24
$-796.0K
$-2.7M
Q1 24
$-3.7M
$-3.5M
Gross Margin
CMCT
CMCT
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
CMCT
CMCT
IRIX
IRIX
Q4 25
-125.6%
Q3 25
-47.7%
-11.3%
Q2 25
-30.3%
-6.9%
Q1 25
-19.0%
-1.7%
Q4 24
-128.8%
-3.9%
Q3 24
-36.9%
-16.1%
Q2 24
-1.6%
-20.9%
Q1 24
-10.7%
-28.0%
Net Margin
CMCT
CMCT
IRIX
IRIX
Q4 25
-125.8%
Q3 25
-47.5%
-12.6%
Q2 25
-30.3%
-7.3%
Q1 25
-18.9%
-14.2%
Q4 24
-129.8%
-6.6%
Q3 24
-36.3%
-16.7%
Q2 24
-2.3%
-21.2%
Q1 24
-11.0%
-29.5%
EPS (diluted)
CMCT
CMCT
IRIX
IRIX
Q4 25
$-3.89
Q3 25
$-23.52
$-0.09
Q2 25
$-18.94
$-0.06
Q1 25
$-20.73
$-0.10
Q4 24
$97.71
$-0.05
Q3 24
$-305.04
$-0.12
Q2 24
$-98.64
$-0.16
Q1 24
$-125.46
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$15.4M
$6.0M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
Total Assets
$859.2M
$29.2M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
IRIX
IRIX
Q4 25
$15.4M
$6.0M
Q3 25
$17.3M
$5.6M
Q2 25
$27.8M
$6.8M
Q1 25
$19.8M
$7.2M
Q4 24
$20.3M
$2.4M
Q3 24
$18.5M
$3.9M
Q2 24
$29.3M
$4.1M
Q1 24
$21.3M
$5.4M
Total Debt
CMCT
CMCT
IRIX
IRIX
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
$1.0M
Q3 24
$478.3M
$1.4M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
IRIX
IRIX
Q4 25
$265.4M
Q3 25
$281.9M
$4.7M
Q2 25
$287.1M
$6.1M
Q1 25
$293.0M
$852.0K
Q4 24
$304.5M
$2.1M
Q3 24
$321.0M
$2.6M
Q2 24
$351.1M
$4.2M
Q1 24
$369.9M
$6.5M
Total Assets
CMCT
CMCT
IRIX
IRIX
Q4 25
$859.2M
$29.2M
Q3 25
$871.8M
$28.4M
Q2 25
$885.0M
$31.6M
Q1 25
$882.3M
$34.2M
Q4 24
$889.6M
$29.1M
Q3 24
$868.0M
$30.2M
Q2 24
$891.2M
$31.2M
Q1 24
$887.5M
$34.1M
Debt / Equity
CMCT
CMCT
IRIX
IRIX
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
0.48×
Q3 24
1.49×
0.53×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
IRIX
IRIX
Operating Cash FlowLast quarter
$5.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
IRIX
IRIX
Q4 25
$5.8M
Q3 25
$3.7M
$-1.2M
Q2 25
$-2.5M
$-397.0K
Q1 25
$1.2M
$-1.1M
Q4 24
$17.0M
$-1.2M
Q3 24
$10.3M
$-3.1M
Q2 24
$3.9M
$-1.3M
Q1 24
$1.6M
$-1.6M
Free Cash Flow
CMCT
CMCT
IRIX
IRIX
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
CMCT
CMCT
IRIX
IRIX
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
CMCT
CMCT
IRIX
IRIX
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons